Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty

NCT04878497 · clinicaltrials.gov ↗

UNKNOWN

Status

1000000

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Frailty
Anticoagulant-induced Bleeding
Stroke

Interventions

DRUG: Warfarin
DRUG: Dabigatran
DRUG: Rivaroxaban
DRUG: Apixaban
DRUG: Edoxaban

Sponsor

Brigham and Women's Hospital